Company intelligence / Profile preview

HAII

Seoul, Seoul, South Koreahaiiglobal.com ↗

Ownership: Private
Development stage: Phase 1

Overview

HAII has developed several digital therapeutics using AI-driven digital biomarkers. Its lead product, AnzeiLax, is in Phase IV targeting GAD and depression. The company’s dementia prevention tool Alzguard-T was recognized as an innovative solution by the Korean government. Clinical trials are ongoing or approved for both its dementia diagnostic device (Alzguard) and post-stroke speech therapy app (Repeech), with US IRB approval from Massachusetts General Hospital secured for the latter. The company has accumulated one of the world’s largest datasets of digital biomarkers.

Therapeutic areas: PsychiatryNeurology
Modalities: Digital therapeuticDevice (mobile app-based)
Industry: Digital Health Medical Devices

Drug pipeline

1 asset

repeech

Phase 1

Indications: Speech disorders, Post-stroke speech impairment

Partnerships

Eisai Co., Ltd. – exclusive license-out contract for cognitive function improvement service appKMI – partnership to supply mental health screening appsIM Rehabilitation Hospital – collaboration on development/commercialization of Repeech

Beyond the preview

Go deeper on HAII.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on HAII.

Explore the full profile